Categories: Automobile

Flexsys Announces Price Increase for Insoluble Sulfur in India

AKRON, Ohio, June 18, 2025 /PRNewswire/ — Flexsys has announced that it will increase the price of Insoluble Sulfur products sold in India by $0.25/kg, effective for all shipments on or after July 1, 2025, or as permitted by customer contracts. This adjustment is attributed to elevated raw material costs, evolving market conditions, and increased investments in research and development aimed at producing innovative, sustainable, and higher-performing products.

- Advertisement -

About Flexsys

- Advertisement -

Flexsys is a global specialty chemicals and materials technology company dedicated to innovating and producing a range of tire additives. Our mission is to enable tire companies to enhance tire performance and manufacturing productivity while promoting sustainability through innovation. Headquartered in Akron, Ohio, with manufacturing facilities across North America, South America, Europe, and Asia, our global team is committed to ensuring the success of our customers.

- Advertisement -

www.flexsys.com

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/flexsys-announces-price-increase-for-insoluble-sulfur-in-india-302484468.html

- Advertisement -
PRNW Agency

Recent Posts

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

ZUG, Switzerland, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Ms. Kazem brings extensive and global expertise…

18 hours ago

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

6 days ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

2 weeks ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

2 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago